Product Browser

Last updated: 2022/7/3

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location
Bulk order
Custom Services
2019 Next Day Shipping

Anti-Bevacizumab monoclonal antibody, clone 6C3 

  • Catalog # : MAB23088
  • Visit Frequency :
  • Countries :
  • Specification
  • Product Description:
  • Mouse monoclonal antibody raised against Bevacizumab.
    Target gene is VEGFA.
  • Immunogen:
  • Bevacizumab.
  • Host:
  • Mouse
  • Specificity:
  • The product is specific for Bevacizumab. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody : Anti-Bevacizumab monoclonal antibody, clone 4H1 (Cat # MAB23087).
  • Form:
  • Lyophilized
  • Preparation Method:
  • The antibody is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Bevacizumab.
  • Purification:
  • Protein A purification
  • Isotype:
  • IgG1, lambda
  • Recommend Usage:
  • Blocking (0.1-10 ug/mL)
    ELISA (0.01-0.1 ug/mL (Direct/Indirect/Inhibitory))
    Sandwich ELISA
    The optimal working dilution should be determined by the end user.
  • Storage Buffer:
  • Lyophilized from PBS, pH 7.4 (0.02% sodium azide).
  • Storage Instruction:
  • Store at -20°C. The lyophilized product remains stable up to 1 year at -20°C from date of receipt.
    After reconstitution with deionized water (or equivalent) to a final concentration of 0.5 mg/mL, it can be stored for 2-3 weeks at 2-8°C or for up to 12 months at -20°C or below.
    Aliquot to avoid repeated freezing and thawing.
  • Note:
  • This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Inhibitory IC50:
  • 0.157 ug/mL
  • Applications
  • Enzyme-linked Immunoabsorbent Assay
  • Enzyme-linked Immunoabsorbent Assay
  • ELISA binding of Anti-Bevacizumab monoclonal antibody, clone 6C3 (Cat # MAB23088) with Bevacizumab. Coating antigen: Bevacizumab, 1 ug/mL. Anti-Bevacizumab monoclonal antibody, clone 6C3 dilution start from 1000 ng/mL. EC50 = 8.735 ng/mL. While the antibody does not recognize the human IgG (data not shown).
  • Sandwich ELISA
  • Sandwich ELISA
  • The Sandwich ELISA assay is developed by using Anti-Bevacizumab monoclonal antibody, clone 4H1 (Cat # MAB23087) and Anti-Bevacizumab monoclonal antibody, clone 6C3 (Cat # MAB23088) as the capture and detection antibodies, respectively. In this ELISA assay, Anti-Bevacizumab monoclonal antibody, clone 6C3 was labeled with Biotin. The sensitivity is less than 78 pg/mL.
  • Blocking
  • Blocking
  • Anti-Bevacizumab monoclonal antibody, clone 6C3 (Cat # MAB23088) blocks Bevacizumab binding with VEGF165 protein. Coating antigen: VEGF165, 1 ug/mL. Bevacizumab final concentration: 0.1 ug/mL. Anti-Bevacizumab monoclonal antibody, clone 6C3 dilutions start from 10 ug/mL. IC50 = 0.157 ug/mL.
  • Application Image
  • Enzyme-linked Immunoabsorbent Assay
  • Enzyme-linked Immunoabsorbent Assay
  • enlarge
  • Gene Information
  • Entrez GeneID:
  • 7422
  • Gene Name:
  • VEGFA
  • Gene Alias:
  • MGC70609,VEGF,VEGF-A,VPF
  • Gene Description:
  • vascular endothelial growth factor A
  • Gene Summary:
  • This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. [provided by RefSeq
  • Other Designations:
  • vascular endothelial growth factor isoform VEGF165,vascular permeability factor
  • Related Disease
  • RSS
  • YouTube
  • Linkedin
  • Facebook